Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A Practical Guide to Implementing SMART in Asthma Management.
Adherence to performance measures and outcomes among men treated for prostate cancer.
Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adherence to performance measures and outcomes among men treated for prostate cancer.
Adherence to performance measures and outcomes among men treated for prostate cancer. J Urol. 2014 Sep; 192(3):743-8.
View in:
PubMed
subject areas
Aged
Cohort Studies
Guideline Adherence
Humans
Male
Prostatic Neoplasms
Quality of Health Care
Retrospective Studies
authors with profiles
Ted Skolarus